The brain reward system as a structural basis of dependence

Homeostasis in Health and Disease

Volumn 40, Issue 1-2, 2000, Pages 1-6

  Herink, J ^a  

^a NONE

Author keywords

Dependence; Mediators; Reward system

Indexed keywords

EID: 0039840437     PISSN: 09607560     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Antelman, S.M., Soares, J.C., Gershon, S. Time-dependent sensitization - possible implications for clinical psychopharmacology. Behav. Pharmacology, 8, 505-514, 1997.
2. Beckstead, R.M. A survey of medical neuroscience. Springer-Verlag, New York, 288-297, 1996.
3. Benkert, O., Wetzel, H., Szegedi, A. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder. Int. Clin. Psychopharmacol., 8, 3-14, 1993.
4. Benloucif, S., Kegan, M.J., Galloway, M.P. Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther., 265, 373-377, 1993.
5. Blum, K., Cull, J.G., Braverman, E.R., Comings, D.E. Reward deficiency syndrome. Amer. Scientist, 84, 132-145, 1996.
6. Blum, K., Noble, E.P. The sobering D2 story. Science, 265, 1346-1347, 1994.
7. Blum, K., Noble, E.P., Sheridan, A. Montgmorery, A., Ritchie, T., Jagadeeswaran, P., Nogami, H., Briggs, A.H., Cohn, J.B. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA, 263, 2055-2060, 1990.
8. Burt, A.M. Textbook of neuroanatomy. W.B. Saunders Co., Philadelphia, 479-501, 1993.
9. Diana, M., Pistis, M., Muntoni, A., Gessa, G. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats J.Pharmacol. Exp. Ther., 272, 781-785, 1995.
10. Jirák, R., Howardová, A. New trends in the treatment of Alzheimers disease. Homeostasis, 39, 102-106, 1999.
11. Kaplan, H.I., Sadock, B.J. Synopsis of psychiatry, 8th ed. Williams and Wilkins, Baltimore, 378-395, 1998.
12. Kiyatkin, E.A. Functional significance of mesolimbic dopamine. Neurosci.Biohehav. Rev., 19, 573-598, 1995.
13. Koob, G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. TIPS, 13, 177-184, 1992.
14. Koob, G.F., Maldonado, R., Stinus, L. Neural substrates of opiate withdrawal. TIPS, 15, 186-191, 1992.
15. LeDoux, J.E. Emotional memory systems in the brain. Brain Behav. Res., 58, 69-79, 1993.
16. LeDoux, J.E. Emotional memory: In search of systems and synapses. Ann. NY Acad. Sci., 702, 149-157, 1993.
17. Linnoila, M., Virkkunen, M., George, T., Higley, D. Impulse control disorders. Int. Clin. Psychopharmacol., 8 (suppl.), 53-56, 1993.
18. Longman family dictionary. Aventinum, Praha, 827, 1991.
19. Macchi, G. Anatomical substrate of emotional reactions. In Handbook of neuropsychology, F.Boller and F.Grafman (eds.), Elsevier Science Publ. Amsterdam, 383-303, 1989.
20. Markou, A., Kosten, T.R., Koob, G.F. Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology, 18, 135-174, 1998.
21. Robinson, T.E., Berridge, K.C. The neural basis of drug craving: An incentive-senzitization theory of addiction. Brain Res. Behav., 18, 247-291, 1993.
22. Rosch, P.J. Parkinson's and Alzheimer's disease: The role of stress. Homeostasis, 39, 107-111, 1999.
23. Stefano, G.B., Fricchione, G.L. The biology of deception: Emotion and morphine. Med. Hypotheses, 44, 49-52, 1995.
24. Stolerman, I. Drugs of abuse: Behavioural principles, methods and terms. TIPS, 13, 170-176, 1992.
25. Valchář, M. Genetic and diseases of the central nervous system (in Czech). Psychiatrie, 2, 231-237, 1998.
26. White, F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Ann Rev. Neurosci., 19, 405-436, 1996.
27. Witter, M.P., Groenewegen, H.J. Organizational principles of hippocampal connections. In The temporal lobes and the limbic system,M.R. Trimble and T.G. Bolwig (eds.), Wrightson Biomedical Publ. LTD, Petersfield, 37-60, 1992.